Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma

International Journal of Medical Sciences

Volumn 11, Issue 1, 2013, Pages 109-118

  Pei, Xiao Juan ^a   Wu, Tong Tong ^a   Li, Bin ^b   Tian, Xiao Ying ^c   Li, Zhi ^b   Yang, Qing Xu ^a  

^a HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

DJ 1; Invasion and metastasis; Macrophage migration inhibitory factor (MIF); Nasopharyngeal carcinoma (NPC); Prognosis

Indexed keywords

DJ 1 PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; SMALL INTERFERING RNA; ISOMERASE; MIF PROTEIN, HUMAN; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PROTEIN KINASE B; SIGNAL PEPTIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; TUMOR INVASION; WESTERN BLOTTING; YOUNG ADULT; CASE CONTROL STUDY; CELL MOTION; DJ-1; GENETICS; INVASION AND METASTASIS; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF); METABOLISM; MIDDLE AGED; MORTALITY; NASOPHARYNGEAL CARCINOMA (NPC); NASOPHARYNX; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

DJ-1; INVASION AND METASTASIS; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF); NASOPHARYNGEAL CARCINOMA (NPC); PROGNOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRAMOLECULAR OXIDOREDUCTASES; LYMPHATIC METASTASIS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; ONCOGENE PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; YOUNG ADULT;

EID: 84891527578     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.7264     Document Type: Article

References (47)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002; 12:421-429.
2. Razak AR, Siu LL, Liu FF, et al. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010; 46:1967-1978.
3. El-Sherbieny E, Rashwan H, Lubis SH, et al. Prognostic factors in patients with nasopharyngeal carcinoma treated in Hospital Kuala Lumpur. Asian Pac J Cancer Prev. 2011; 12:1739-1743.
4. O'Sullivan B. Nasopharynx cancer: therapeutic value of chemoradiotherapy. Int J Radiat Oncol Biol Phys.2007; 69:S118-S121.
5. Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for naso-pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003; 129:794-9.
6. Pua KC, Khoo AS, Yap YY, et al. Nasopharyngeal Carcinoma Database. Med J Malaysia. 2008; 63 (Suppl C): 59-62.
7. Bach JP, Rinn B, Meyer B, et al. Role of MIF in inflammation and tumorigene-sis. Oncology. 2008; 75:127-133.
8. Wang XB, Tian XY, Li Y, et al. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. J Neurooncol. 2012; 106:43-51.
9. Lee H, Rhee H, Kang HJ, et al. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol. 2008; 129:772-779.
10. Ren Y, Tsui HT, Poon RT, et al. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer. 2003; 107:22-29.
11. Chen YC, Zhang XW, Niu XH, et al. Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overex-pressed in prostate cancer. Oncogene. 2010; 29:3067-3078.
12. Xu X, Wang B, Ye C, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008; 261:147-157.
13. Shimizu T, Abe R, Nakamura H, et al. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun. 1999; 264:751-758.
14. Rendon BE, Roger T, Teneng I, et al. Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem. 2007; 282:29910-29918.
15. Ogawa H, Nishihira J, Sato Y, et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine. 2000; 12:309-314.
16. Takahashi N, Nishihira J, Sato Y, et al. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med. 1998, 4:707-714.
17. Bach JP, Deuster O, Balzer-Geldsetzer M, et al. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer. 2009; 115:2031-2040.
18. Lue H, Thiele M, Franz J, et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007; 26:5046-5059.
19. Li GQ, Xie J, Lei XY, et al. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol. 2009; 15:5541-5548.
20. Lee CY, Su MJ, Huang CY, et al. Macrophage migration inhibitory factor increases cell motility and up-regulates αvβ3 integrin in human chondrosarcoma cells. J Cell Biochem. 2012; 113:1590-1598.
21. Li Z, Ren Y, Wu QC, et al. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloprotein-ase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. Chin Med J (Engl). 2004; 117:107-114.
22. Liao B, Zhong BL, Li Z, et al. Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. J Surg Oncol. 2010; 102:844-851.
23. Nagakubo D, Taira T, Kitaura H, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997; 231:509-513.
24. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003; 299:256-259.
25. Davidson B, Hadar R, Schlossberg A, et al. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol. 2008; 39:87-95.
26. Bindukumar B, Schwartz S, Aalinkeel R, et al. Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells. Prostate. 2008; 68:1531-1545.
27. Tsuchiya B, Iwaya K, Kohno N, et al. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast. His top athology. 2012; 61:69-77.
28. He X, Zheng Z, Li J, et al. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. Carcinogenesis. 2012; 33:555-562.
29. Bai J, Guo C, Sun W, et al. DJ-1 may contribute to metastasis of non-small cell lung cancer. Mol Biol Rep. 2012; 39:2697-2703.
30. Zhu XL, Wang ZF, Lei WB, et al. DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma. Cancer Sci. 2010; 101:1320-1325.
31. Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys. 1994; 30:1037-1042.
32. Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001; 10:657-62.
33. Xie LQ, Bian LJ, Li Z, et al. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma. Ann Surg Oncol. 2010; 17:1927-1936.
34. Hira E, Ono T, Dhar DK, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer. 2005; 103:588-598.
35. Legendre H, Decaestecker C, Nagy N, et al. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol. 2003; 16:491-504.
36. Muramaki M, Miyake H, Yamada Y, et al. Clinical utility of serum macro-phage migration inhibitory factor in men with prostate cancer as a novel bi-omarker of detection and disease progression. Oncol Rep. 2006; 15:253-257.
37. Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol. 2009; 34:881-895.
38. Kraljevic Pavelic S, Sedic M, et al. Metastasis: new perspectives on an old problem. Mol Cancer. 2011; 10:22.
39. Ren Y, Law S, Huang X, et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg. 2005; 242:55-63.
40. Vasseur S, Afzal S, Tardivel-Lacombe J, et al. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci USA. 2009; 106:1111-1116.
41. He XY, Liu BY, Yao WY, et al. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer. J Dig Dis. 2011; 12:131-137.
42. Le Naour F, Misek DE, Krause MC, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res. 2001; 7:3328-3335.
43. Yuen HF, Chan YP, Law S, et al. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17:3593-3602.
44. Liu S, Yang Z, Wei H, et al. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma. Hepatogastroenterology. 2010; 57:1247-1256.
45. Fang M, Zhong XY, Du B, et al. Role of DJ-1-induced PTEN down-regulation in migration and invasion of human glioma cells. Chin J Cancer. 2010; 29:988-994.
46. Aleyasin H, Rousseaux MW, Marcogliese PC, et al. DJ-1 protects the nigro-striatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci USA. 2010; 107:3186-3191.
47. Yang Y, Gehrke S, Haque ME, et al. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA. 2005; 102:13670-13675.